In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
OverviewLeqembi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease. It is specifically indicated for individuals in the mild cognitive impairment or mild dementia stage of…
Join